Participant-Centric RTSM Designs 

As clinical trials become increasingly complex, traditional supply management approaches are being challenged by the unique demands of cell and gene therapies, radiopharmaceuticals, and direct-to-participant (DTP) models. From participant-specific manufacturing and time-sensitive treatments to complex logistics and privacy requirements, clinical teams need RTSM solutions designed to support the individual participant throughout the supply journey.

This white paper explores how participant-centric RTSM design, intelligent supply coordination, and end-to-end accountability can help sponsors and clinical teams navigate these challenges while protecting treatment integrity, improving operational visibility, and supporting more flexible clinical trial delivery.

What you’ll learn

• How emerging therapies and direct-to-participant models are reshaping clinical supply management
• How RTSM can support participant-specific manufacturing, chain of identity, and treatment traceability
• Why time-critical usability windows, cold-chain management, and specialized logistics require greater coordination
• How privacy-aware workflows can enable secure and efficient direct-to-participant supply delivery
• How configurable RTSM capabilities can strengthen compliance, accountability, and operational oversight throughout the supply lifecycle

Discover how participant-centric RTSM can help create a more connected, controlled, and adaptable approach to clinical supply management, keeping participants at the center of every decision.